From quality of publication to quality of care: Translating trials to practice

Journal of the National Cancer Institute

Volumn 102, Issue 10, 2010, Pages 670-671

  Dancey, Janet E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; ONCOLOGY; PREMEDICATION; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ACCESS TO INFORMATION; BENCHMARKING; CLINICAL PROTOCOLS; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; JOURNALISM, MEDICAL; MEDICAL ONCOLOGY; NEOPLASMS; PERIODICALS AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 77952915654     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq142     Document Type: Editorial

References (16)

1. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996; 276(8):637-639.
2. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(9263):1191-1194. (Pubitemid 32378696)
3. Ioannidis JP, Evans SJ, Gotzsche PC, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141(10):781-788.
4. Lee IH, Hayman JA, Landrum MB, et al. Treatment recommendations for locally advanced, non-small-cell lung cancer: the infuence of physician and patient factors. Int J Radiat Oncol Biol Phys. 2009;74(5):1376-1384.
5. Duff JM, Leather H, Walden EO, LaPlant KD, George TJ Jr. Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application. J Natl Cancer Inst. 2010;102(10): 702-705.
6. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med. 2009; 169(19):1756-1761.
7. Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med. 2009;169(19):1737-1739.
8. Sinha S, Ashby E, Jayaram R, Grocott MP. Quality of reporting in randomized trials published in high-quality surgical journals. J Am Coll Surg. 2009;209(5):565-571 e1.
9. Cherny NI, Abernethy AP, Strasser F, Sapir R, Currow D, Zafar SY. Improving the methodologic and ethical validity of best supportive care studies in oncology: lessons from a systematic review. J Clin Oncol. 2009; 27(32):5476-5486.
10. Kommoss S, Harter P, Traut A, et al. Compliance to consensus recommendations, surgeon's experience, and introduction of a quality assurance and management program: infuence on therapy of early-stage ovarian carcinoma. Int J Gynecol Cancer. 2009;19(4):787-793.
11. Blayney DW, McNiff K, Hanauer D, Miela G, Markstrom D, Neuss M. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center. J Clin Oncol. 2009;27(23):3802-3807.
12. Leonard MS, Cimino M, Shaha S, McDougal S, Pilliod J, Brodsky L. Risk reduction for adverse drug events through sequential implementation of patient safety initiatives in a children's hospital. Pediatrics. 2006;118(4): e1124-e1129.
13. Kedikoglou S, Syrigos K, Skalkidis Y, Ploiarchopoulou F, Dessypris N, Petridou E. Implementing clinical protocols in oncology: quality gaps and the learning curve phenomenon. Eur J Public Health. 2005;15(4):368-371.
14. Bleyer A. The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer. 2010;54(2):238-241.
15. Howell DL, Ward KC, Austin HD, Young JL, Woods WG. Access to pediatric cancer care by age, race, and diagnosis, and outcomes of cancer treatment in pediatric and adolescent patients in the state of Georgia. J Clin Oncol. 2007;25(29):4610-4615.
16. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362(9391):1225-1230.